An update on our notification of 14 December 2018. ProPharma/PWR has increased the allocation to 6 per week per customer (does not apply to PN01) until further notice. This remains a serious issue and this is all we can do to assist and work through the supply issue. This action is not taken lightly and will not suit all pharmacies.…
Click here to read the notification from AFT relating to the above mention product. This is a short term supply issue. ProPharma / PWR have again been proactive and have set in place an allocation of 1 per customer per week. We accept one size does not fit all, but in these instances where very little if any notice is…
Click here to access the analysis relating to the above mentioned product. To change brands early could prove to be costly. ProPharma / PWR in association with AFT have reduced the price ex manufacturer of Fenpaed effective immediately (from $2.39 to $1.88 excluding GST) offering you a significant opportunity to increase your $ margin on this product. On a high…
The following product(s) are being reference priced from 1 April 2019, which comes about from an alternative being award the Sole Supply within the next few months. We are highlighting these so that you have time to manage the transition. No price support provided for the following therefore price will not be reduced until stocks in the supply chain currently…
Following on from our original notification of the 1 March 2019 and subsequent notification of 13 March 2019 and 19 March 2019 relating to the above mentioned subject, we provided further and hopefully final information. The Ministry of Health have reclassified a specific range of medications to Restricted Medicines (Pharmacist Only), and in one specific case to Prescription Only. We…
Aspen Pharmacare has advised the discontinuation of Questran-Lite. Supply of the Questran-Lite S29 Pharmacode 255588 remains available within the supply chain. As of the date of this notification ProPharma / PWR cannot accept Questran-Lite or Questran-Lite S29 for credit under any circumstances. Please note that both of the above products are due to be delisted from the Pharmaceutical Schedule effective…
Click here to read the notification from Bayer New Zealand Limited relating to several supply issues. Where suppliers have short terms supply issues ProPharma / PWR implement short term allocations. We accept one size does not fit all, but in these instances we need to act on what stock remains available in the supply chain. If you feel these unduly…
Bayer has advised that this product is to be discontinued shortly. Expiry date on existing stock is July 2019. Please note there are supplies within the supply chain at wholesale level. As of the date of this notification ProPharma / PWR cannot accept Ciproxin Suspension for credit under any circumstances. We thank you in anticipation of your ongoing support.
Please be advised that there is to be a change in the unit outer pack size of the above mention product. Current presentation is:- Pharmacode 2548305 Metronidazole Baxter 500mg/100ml solution for infusion bag – 1 unit = 10 viaflex bags (as shown on the left) Schedule Price $55.00 New presentation is:- (anticipated listing May 2019) Pharmacode 2565110 Metronidazole Baxter…
Click here to read Pfizer notification of 22 March 2019 relating to the above mentioned products. As at this date ProPharma / PWR had limited stock of these items. This supply issue is for periods of up to 2 months and we request that you do not stock pile at the potential expense of others. We thank you in anticipation…